Reposted by Sam Lauffer
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
December 9, 2024 at 9:24 PM
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Easy Access to A Firearm
Reposted by Sam Lauffer
ALBICS-AKI trial results from CCR Down Under.
1ry outcome: Overall increased relative risk of 12% in those patients receiving concentrated albumin vs standard care.
#CCRdownunder
1ry outcome: Overall increased relative risk of 12% in those patients receiving concentrated albumin vs standard care.
#CCRdownunder
December 10, 2024 at 3:00 AM
ALBICS-AKI trial results from CCR Down Under.
1ry outcome: Overall increased relative risk of 12% in those patients receiving concentrated albumin vs standard care.
#CCRdownunder
1ry outcome: Overall increased relative risk of 12% in those patients receiving concentrated albumin vs standard care.
#CCRdownunder
Reposted by Sam Lauffer
Just published!
Results from the COSMOS pilot:
COSMOS is a two-part prospective observational study & randomized trial in 250 patients, all of whom had continuous ward respiratory monitoring for 48 postoperative hours.
🧵 A thread!
Results from the COSMOS pilot:
COSMOS is a two-part prospective observational study & randomized trial in 250 patients, all of whom had continuous ward respiratory monitoring for 48 postoperative hours.
🧵 A thread!
December 10, 2024 at 5:09 PM
Just published!
Results from the COSMOS pilot:
COSMOS is a two-part prospective observational study & randomized trial in 250 patients, all of whom had continuous ward respiratory monitoring for 48 postoperative hours.
🧵 A thread!
Results from the COSMOS pilot:
COSMOS is a two-part prospective observational study & randomized trial in 250 patients, all of whom had continuous ward respiratory monitoring for 48 postoperative hours.
🧵 A thread!
Reposted by Sam Lauffer
What is a ‘safe dose’ of LA? I read an article when training on how we should avoid using traditional ‘safe mg/kg doses’ and think more about the site, the patient, co-morbidities etc.
I can’t remember where I read this but it’s something that’s stayed with me.
Even so, this case is a rare event!
I can’t remember where I read this but it’s something that’s stayed with me.
Even so, this case is a rare event!
Rare case of LA skin infiltration at the facet joint causing an accidental high spinal #freeforaweek
Was infiltration too deep or did LA spread into the erector spinae?
#regional #AnSky #anaesthesia
https://buff.ly/41ihb68
Was infiltration too deep or did LA spread into the erector spinae?
#regional #AnSky #anaesthesia
https://buff.ly/41ihb68
December 5, 2024 at 10:29 AM
What is a ‘safe dose’ of LA? I read an article when training on how we should avoid using traditional ‘safe mg/kg doses’ and think more about the site, the patient, co-morbidities etc.
I can’t remember where I read this but it’s something that’s stayed with me.
Even so, this case is a rare event!
I can’t remember where I read this but it’s something that’s stayed with me.
Even so, this case is a rare event!